Effect Of Vamana Karma(emesis) In The Management Of Obesity

A Clinical Study to Evaluate The Efficacy Of Vamana Karma In The Management Of Dyslipidemia

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2018/01/011573

Enrollment

Registered

2018-01-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- obese patient dyslipidemia

Interventions

Intervention1: Group A: â?? Patients in this group will be administered with 2 Sittings of Vamana procedure. FirstDeepan-Paachan thenSnehapaanfollowed by administration ofvamaka dravya. Then,Samsarj

Eligibility

Inclusion criteria

Inclusion criteria: 1. S.Cholesterol - > 200 mg/dl 2. S.Triglyceride - > 150 mg/dl 3. S. LDL - > 110 mg/dlNCEP 4. S.VLDL - > 41 mg/dlATP III Guidelines 5. CHO/HDL Ratio - >4.97 mg/dl 6. LDL/HDL Ratio - >3.55 mg/dl11 7. Patient having any one the above criteria 8. Patients fit for Vamana Karma

Exclusion criteria

Exclusion criteria: 1. Age 60 years 2. Patients having serious cardiac ailments as- Myocardial Infarction, malignant hypertension, cardiac failure. 3. Patients with clear diagnosis of DM Type I and type II. 4. Patients having disordered KFT or renal markers. 5. Patients having untreated Thyroid Disorders. 6. Drug induced Hyperlipidemia e.g. - Glucocorticoid induced. 7. Pregnant and lactating females.

Design outcomes

Primary

Measure	Time frame
To Evaluatethe efficacy of Vamana Karma in the management of Dyslipidemia.Complete remission : 100% relief Markedly improvement : 76-99% relief Moderately improvement: 51%-75% relief Mild Improvement : 26%-50% relief Unchanged : 25% relief Timepoint: 2 months	—

Secondary

Measure	Time frame
exacerbation in sign and symptomsTimepoint: 1 month	—

Countries

India

Contacts

Public Contactshipra singh

Rishikul Campus Uttarakhand Ayurved University Haridwar

virgo.alok@gmail.com09045087121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026